Clinical features of PPP2 syndrome type R5D (Jordan's syndrome) to support standardization of care
Molecular Case Studies · 2023
DOI: 10.1101/mcs.a006285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Case Studies, 2023. Verfasst von Alexis D Levine und 1 weiteren Autor:innen. Beteiligte Einrichtung: New York Medical College, Valhalla, New York 10595, USA; alevine220@gmail.com. Hauptthemen laut MEDLINE: Intellectual Disability, Neurodevelopmental Disorders, Autistic Disorder. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PPP2 syndrome type R5D, or Jordan's syndrome, is a neurodevelopmental disorder caused by pathogenic missense variants in PPP2R5D , a β-subunit of the Protein Phosphatase 2A (PP2A). The condition is characterized by global developmental delays, seizures, macrocephaly, ophthalmological abnormalities, hypotonia, attention disorder, social and sensory challenges often associated with autism, disordered sleep, and feeding difficulties. Among affected individuals, there is a broad spectrum of severity, and each person only has a subset of all associated symptoms. Some, but not all, of the clinical variability is due to differences in the PPP2R5D genotype. These suggested clinical care guidelines for the evaluation and treatment of individuals with PPP2 syndrome type R5D are based on data from 100 individuals reported in the literature and from an ongoing natural history study. As more data are available, particularly for adults and regarding treatment response, we anticipate that revisions to these guidelines will be made.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- New York Medical College, Valhalla, New York 10595, USA; alevine220@gmail.com.
- Columbia University, New York, New York 10032, USA.
ORCID-Profile: Alexis D Levine, Wendy K Chung
Zitieren
APA
Levine, A. D., & Chung, W. K. (2023). Clinical features of PPP2 syndrome type R5D (Jordan's syndrome) to support standardization of care. Molecular Case Studies. https://doi.org/10.1101/mcs.a006285
Vancouver
Levine AD, Chung WK. Clinical features of PPP2 syndrome type R5D (Jordan's syndrome) to support standardization of care. Molecular Case Studies. 2023. doi:10.1101/mcs.a006285
BibTeX
@article{Levine2023,
author = {Levine, Alexis D and Chung, Wendy K},
title = {Clinical features of PPP2 syndrome type R5D (Jordan's syndrome) to support standardization of care},
journal = {Molecular Case Studies},
year = {2023},
doi = {10.1101/mcs.a006285}
}
EUVIMED